TrialCNS drugs2020

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.

Elinor Ben-Menachem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.